List of Tables

Table 1. Nucleic Acid Based Gene Therapy Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Nucleic Acid Based Gene Therapy Market Restraints

Table 3. Nucleic Acid Based Gene Therapy Market Trends

Table 4. Nucleic Acid Based Gene Therapy Industry Policy

Table 5. Global Nucleic Acid Based Gene Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Nucleic Acid Based Gene Therapy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Nucleic Acid Based Gene Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Nucleic Acid Based Gene Therapy Mergers & Acquisitions, Expansion Plans

Table 9. Global Nucleic Acid Based Gene Therapy Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Nucleic Acid Based Gene Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China Nucleic Acid Based Gene Therapy Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Nucleic Acid Based Gene Therapy Upstream (Raw Materials)

Table 14. Global Nucleic Acid Based Gene Therapy Typical Customers

Table 15. Nucleic Acid Based Gene Therapy Typical Distributors

Table 16. by Type, Global Nucleic Acid Based Gene Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global Nucleic Acid Based Gene Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Nucleic Acid Based Gene Therapy Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global Nucleic Acid Based Gene Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2020-2031

Table 23. Wave Life Sciences Company Information, Head Office, Market Area, and Industry Position

Table 24. Wave Life Sciences Company Profile and Main Business

Table 25. Wave Life Sciences Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 26. Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Wave Life Sciences Recent Developments

Table 28. Imugene Company Information, Head Office, Market Area, and Industry Position

Table 29. Imugene Company Profile and Main Business

Table 30. Imugene Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 31. Imugene Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Imugene Recent Developments

Table 33. Sarepta Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 34. Sarepta Therapeutics Company Profile and Main Business

Table 35. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 36. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Sarepta Therapeutics Recent Developments

Table 38. Alnylam Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 39. Alnylam Pharmaceuticals Company Profile and Main Business

Table 40. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 41. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. Alnylam Pharmaceuticals Recent Developments

Table 43. Ionis Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 44. Ionis Pharmaceuticals Company Profile and Main Business

Table 45. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 46. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Ionis Pharmaceuticals Recent Developments

Table 48. Moderna Company Information, Head Office, Market Area, and Industry Position

Table 49. Moderna Company Profile and Main Business

Table 50. Moderna Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 51. Moderna Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. Moderna Recent Developments

Table 53. BioNTech Company Information, Head Office, Market Area, and Industry Position

Table 54. BioNTech Company Profile and Main Business

Table 55. BioNTech Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 56. BioNTech Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. BioNTech Recent Developments

Table 58. Nutcracker Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 59. Nutcracker Therapeutics Company Profile and Main Business

Table 60. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 61. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. Nutcracker Therapeutics Recent Developments

Table 63. Deep Genomics Company Information, Head Office, Market Area, and Industry Position

Table 64. Deep Genomics Company Profile and Main Business

Table 65. Deep Genomics Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 66. Deep Genomics Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. Deep Genomics Recent Developments

Table 68. Sirnaomics Company Information, Head Office, Market Area, and Industry Position

Table 69. Sirnaomics Company Profile and Main Business

Table 70. Sirnaomics Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 71. Sirnaomics Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 72. Sirnaomics Recent Developments

Table 73. Laronde Company Information, Head Office, Market Area, and Industry Position

Table 74. Laronde Company Profile and Main Business

Table 75. Laronde Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 76. Laronde Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 77. Laronde Recent Developments

Table 78. Abogen Biosciences Company Information, Head Office, Market Area, and Industry Position

Table 79. Abogen Biosciences Company Profile and Main Business

Table 80. Abogen Biosciences Nucleic Acid Based Gene Therapy Models, Specifications, and Application

Table 81. Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 82. Abogen Biosciences Recent Developments

List of Figures

Figure 1. Nucleic Acid Based Gene Therapy Picture

Figure 2. Global Nucleic Acid Based Gene Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 3. China Nucleic Acid Based Gene Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China Nucleic Acid Based Gene Therapy Market Share of Global, 2020-2031

Figure 5. Global Nucleic Acid Based Gene Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China Nucleic Acid Based Gene Therapy Key Participants, Market Share, 2024

Figure 7. Nucleic Acid Based Gene Therapy Industry Chain

Figure 8. Nucleic Acid Based Gene Therapy Procurement Model

Figure 9. Nucleic Acid Based Gene Therapy Sales Model

Figure 10. Nucleic Acid Based Gene Therapy Sales Channels, Direct Sales, and Distribution

Figure 11. Anti-Sence and Anti-Gene

Figure 12. Short Inhibitory Sequences

Figure 13. Gene Transfer Therapy

Figure 14. Nucleoside Analogs

Figure 15. Ribozymes

Figure 16. Aptamers

Figure 17. Others

Figure 18. by Type, Global Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 19. by Type, Global Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2020-2031

Figure 20. Hospitals and Clinics

Figure 21. Academic and Research Institutes

Figure 22. Others

Figure 23. by Application, Global Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 24. by Application, Global Nucleic Acid Based Gene Therapy Revenue Market Share, 2020-2031

Figure 25. By Region, Global Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2020-2031

Figure 26. North America Nucleic Acid Based Gene Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 27. By Country, North America Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024

Figure 28. Europe Nucleic Acid Based Gene Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 29. By Country, Europe Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024

Figure 30. Asia Pacific Nucleic Acid Based Gene Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 31. By Country/Region, Asia Pacific Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024

Figure 32. South America Nucleic Acid Based Gene Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 33. By Country, South America Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024

Figure 34. Middle East & Africa Nucleic Acid Based Gene Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 35. United States Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 36. by Type, United States Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 37. by Application, United States Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 38. Europe Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 39. by Type, Europe Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 40. by Application, Europe Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 41. China Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 42. by Type, China Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 43. by Application, China Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 44. Japan Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 45. by Type, Japan Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 46. by Application, Japan Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 47. South Korea Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 48. by Type, South Korea Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 49. by Application, South Korea Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 50. Southeast Asia Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 51. by Type, Southeast Asia Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 52. by Application, Southeast Asia Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 53. India Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 54. by Type, India Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 55. by Application, India Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 56. Middle East & Africa Nucleic Acid Based Gene Therapy Consumption Value, 2020-2031, US$ Million

Figure 57. by Type, Middle East & Africa Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 58. by Application, Middle East & Africa Nucleic Acid Based Gene Therapy Consumption Value Market Share, 2024 VS 2031

Figure 59. Research Methodology

Figure 60. Breakdown of Primary Interviews

Figure 61. Bottom-up Approaches

Figure 62. Top-down Approaches